Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 48

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 3
Chunk 48
---
 anti-bribery laws have been enforced aggressively in recent years
and are interpreted broadly to generally prohibit companies, their employees and their third-party intermediaries from authorizing, offering,
or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. If NewGenIvf expands
its business and sales and to the public sector, it may engage with business partners and third-party intermediaries to market its services
and to obtain for it the necessary permits, licenses, and other regulatory approvals. In addition, NewGenIvf or its third-party intermediaries
may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. NewGenIvf
can be held liable for the corrupt or other illegal activities of these third-party intermediaries, its employees, representatives, contractors,
partners and agents, even if it does not explicitly authorize such activities. Detecting, investigating, and resolving actual or alleged
violations of anti-corruption laws can require a significant diversion of time, resources, and attention from senior management. In addition,
noncompliance with anti-corruption, anti-bribery, or anti-money laundering laws could subject it to whistleblower complaints, investigations,
prosecution, enforcement actions, sanctions, settlements, fines, damages, other civil or criminal penalties or injunctions, suspension
or debarment from contracting with certain persons, reputational harm, adverse media coverage, and other collateral consequences. If any
subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if NewGenIvf does not prevail in any possible
civil or criminal proceeding, its business, financial condition and results of operations could be harmed. In addition, responding to
any action will likely result in a materially significant diversion of management’s attention and resources and significant defense
costs and other professional fees, which could adversely affect its business, financial condition and results of operations.

ITEM 4. INFORMATION ON THE COMPANY